Cell Therapy Technologies Market worth $7.91 billion by 2030
The report "Cell Therapy Technologies Market by Product (Media, Sera, Reagents, Vessels, Equipment), Process (Expansion, Isolation, Characterization, Collection, Preservation, Distribution, QC), Type (T-cells, Stem Cells), Application (Cancer) - Global Forecast to 2030 ", is projected to reach USD 7.91 billion by 2030, up from USD 4.41 billion in 2025, with a significant CAGR of 12.4% during the forecast period of 2025 to 2030.
Browse 500 market data Tables and 45 Figures spread through 470 Pages and in-depth TOC on "Cell Therapy Technologies Market by Product (Media, Sera, Reagents, Vessels, Equipment), Process (Expansion, Isolation, Characterization, Collection, Preservation, Distribution, QC), Type (T-cells, Stem Cells), Application (Cancer) - Global Forecast to 2030 "
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/cell-therapy-technologies-market-213334978.html
Multiple factors are fueling the expansion of the global cell therapy technologies market. Key growth drivers include the rising burden of chronic and rare diseases, rapid progress in regenerative medicine, and increasing public and private investment in biotechnology and specialized CGT manufacturing infrastructure. The demand for personalized treatment options and the maturation of advanced gene-editing approaches, such as CRISPR and base/prime editing, are further accelerating the adoption of sophisticated cell processing, engineering, and analytical platforms, thereby significantly boosting market growth.
The media, sera, and reagents segment accounted for the dominant share in 2024.
By product, the market is divided into media, sera, and reagents; cell engineering products; cell culture vessels; cell therapy equipment; systems & software; and other products. In 2024, the Media, sera, and reagents hold a significant market share. Media, sera, and reagents held a leading share because of their indispensable role in supporting efficient cell culture, expansion, and preservation across research and clinical manufacturing. The growing adoption of serum-free and chemically defined formulations has further improved process consistency and scalability, aligning with industry requirements for high-quality, reproducible cell therapy production.
The biopharmaceutical & biotechnology companies segment is estimated to register the highest CAGR from 2025 to 2030.
Based on end user, the market has been classified into biopharmaceutical & biotechnology companies, CROS & CMOs, research institutes, and cell banks. Biopharmaceutical and biotechnology companies accounted for the largest share in 2024, driven by their extensive use of advanced cell expansion systems, closed processing equipment, and single-use technologies for cell-based research and oncology applications. In addition, supportive regulatory pathways, expedited approvals for innovative therapies, the rising burden of chronic diseases, and increasing global healthcare spending are collectively fostering broader adoption of cell therapy technologies and underpinning overall market growth.
Asia Pacific is likely to be the fastest-growing region in the cell therapy technologies market during the forecast period.
Based on region, the cell therapy technologies market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific is rapidly emerging as a significant growth engine, supported by rising investment in healthcare and biomanufacturing infrastructure, expansion of domestic biotechnology sectors, and increasingly supportive government policies for advanced therapies. A growing burden of chronic and rare diseases, combined with a strong interest in regenerative medicine, is intensifying demand for sophisticated cell therapy platforms across the region. Countries such as China, Japan, South Korea, and Australia are at the forefront, with robust R&D pipelines, an increasing number of CGT clinical trials, and the accelerated build-out of GMP facilities, positioning the APAC region as a key contributor to future market expansion.
Prominent players operating in the cell therapy technologies market include Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Lonza (Switzerland), Sartorius AG (Germany), Agilent Technologies Inc. (US), Avantor, Inc. (US), Bio-Techne (US), Avantor, Inc. (US), Fresenius SE & Co KGAA (Germany), BD (US), and Corning Incorporated (US) among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Cell Therapy Technologies Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
